The management of differentiated thyroid cancer using 123I for imaging to assess the need for 131I therapy.

@article{Ali2006TheMO,
  title={The management of differentiated thyroid cancer using 123I for imaging to assess the need for 131I therapy.},
  author={Nidhal Faisal Ali and C Sebastian and R. R. Foley and Iain Murray and Ana L Canizales and Paul J. Jenkins and William Martyn Drake and Piers Nicholas Plowman and G. Michael Besser and Shern L. Chew and Ashley B. Grossman and John P. Monson and Keith E. Britton},
  journal={Nuclear medicine communications},
  year={2006},
  volume={27 2},
  pages={
          165-9
        }
}
BACKGROUND Follow-up of 131I whole-body scanning after 131I ablation is associated with potential stunning. Previous studies have suggested that, for scanning, 123I is more sensitive than 131I in identifying thyroid tissue, but its specificity when positive is less certain. AIM The use of 123I as an imaging agent in place of serial 131I imaging has been evaluated in the surveillance and treatment of differentiated thyroid carcinoma. RESULTS A total of 186 studies in 136 patients with… CONTINUE READING

Topics from this paper.

Citations

Publications citing this paper.
SHOWING 1-10 OF 11 CITATIONS

Current technology in thyroid surgery.

  • ORL; journal for oto-rhino-laryngology and its related specialties
  • 2008